Cargando…

Chloroquine: Cardiac toxicity following off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862852/ http://dx.doi.org/10.1007/s40278-021-90570-8

Ejemplares similares

Azithromycin/chloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Chloroquine/hydroxychloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Azithromycin/chloroquine: Various toxicities following off-label treatment: 2 case reports
Publicado: (2021)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Chloroquine: Off-label use, haemolysis and methaemoglobinaemia: case report
Publicado: (2020)

Chloroquine: High troponin I level following off label use: case report
Publicado: (2021)

Chloroquine/tocilizumab: Leucopenia and liver injury following off-label use: case report
Publicado: (2020)

Chloroquine: Prolonged corrected QT interval following off label use: 2 case reports
Publicado: (2021)

Multiple drugs: Cardiac toxicities following off-label treatment: 3 case reports
Publicado: (2020)

Amiodarone/chloroquine/remdesivir interaction: Hepatotoxicity and off-label therapy: case report
Publicado: (2021)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Tocilizumab: Various toxicities following off label use: 4 case reports
Publicado: (2021)

Anakinra: Various toxicities following off label use: 7 case reports
Publicado: (2021)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Chloroquine/favipiravir/rituximab: COVID-19-pneumonia, off-label use and lack of efficacy: case report
Publicado: (2022)

Ketamine: Various toxicities following off-label use of ketamine: 3 case reports
Publicado: (2021)

Ruxolitinib: Grade 3 liver toxicity following off-label use: case report
Publicado: (2020)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine: Cardiac disorder followed by off-label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Multiple drugs: Various toxicities following off-label use and lack-of-efficacy: case report
Publicado: (2021)

Multiple drugs: Various toxicities, and lack of efficacy following off-label use: case report
Publicado: (2022)

Fluvoxamine/theophylline: Various toxicities following drug interaction and off-label use: case report
Publicado: (2022)

Chloroquine/dalteparin sodium/hydroxycarbamide: Prolongation of the QTc interval secondary to off-label use and lack of efficacy: case report
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac disorders following off label use: 5 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac arrest following off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2022)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Lopinavir/ritonavir/ribavirin: Various toxicities following off-label treatment: case report
Publicado: (2020)

Multiple drugs: Various toxicities following interaction and off-label: 2 case reports
Publicado: (2020)

Lopinavir/ritonavir: Various toxicities following off-label use in COVID-19: 4 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off label use: 5 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: 10 case reports
Publicado: (2021)

Multiple drugs: Toxic epidermal necrolysis and off label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities and off label use: 3 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5pt8qc6r3816u632svpevt665s